NHS Healthcare Roll-Up: Institutional Investment Opportunity
The Market Opportunity
The NHS represents the UK's largest procurement market, spending over £40 billion annually on third-party goods and services through 20,000+ fragmented suppliers. This creates a compelling consolidation opportunity in a market driven by cost containment pressures, digital transformation requirements, and an aging SME supplier base facing succession challenges.
Investment Thesis
We are building a disciplined roll-up vehicle targeting profitable NHS suppliers with £2-50M annual turnover. Our strategy consolidates fragmented supply chains into a unified, compliance-driven platform that delivers superior value to NHS buyers while generating strong returns for investors.
Value Creation Strategy
Operational Integration
Add your pricing strategy. Be sure to include important details like value, length of service, and why it’s unique.
Commercial Amplification
Add your pricing strategy. Be sure to include important details like value.
Digital Transformation
Add your pricing strategy. Be sure to include important details like value.
Professional Management
Add your pricing strategy. Be sure to include important details like value, length of service, and why it’s unique.
Why Partner With Us
Proven Market Access
Proprietary deal flow through NHS procurement networks, M&A advisors, and industry relationships
Disciplined Acquisition Process
Rigorous 100-point scorecard evaluation ensures only quality targets with clear integration pathways
Experienced Leadership Team
NHS procurement expertise, PE-backed growth experience, and regulatory compliance knowledge
Clear Exit Strategy
Multiple paths including IPO (AIM/LSE), strategic trade sale, or PE secondary with strong ESG appeal